Contribute Try STAT+ Today

Kylene Redmond and Deb Foerster both are converts to their continuous glucose monitors, quarter-size devices that measure their blood sugar in real time so they can adjust their diet, their activity, and the medications they take to manage their diabetes.

The automated sensors give both women feedback they can use to better control their disease and manage their daily lives, they said Wednesday at the STAT Health Tech Summit, making the devices a bellwether for other wearables beyond diabetes that are gaining traction in both consumer and clinical markets. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.